Brief: Onward Medical Announces Start Of HemON NL Clinical Study

ONWARD Medical

18/01/2024 06:32

Jan 18 (Reuters) - Onward Medical NV  ONWD.BR :
    * ONWARD® ANNOUNCES START OF HEMON NL CLINICAL STUDY
    * HEMON NL IS EVALUATING USE OF ARC-IM® THERAPY TO ADDRESS
HEMODYNAMIC INSTABILITY AFTER SPINAL CORD INJURY
    * COMPANY PLANS TO ENROLL PARTICIPANTS IN BOTH HEMON AND
HEMON NL
AS IT FINALIZES DESIGN OF EMPOWER BP PIVOTAL STUDY

Source text for Eikon:  ID:nGNE8WN2nR 
Further company coverage:  ONWD.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))